Freenome
Agent46Agent Readiness: 46/100. Above median. Measured by StartupHub.ai. Median 41.Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
About
Freenome is a biotechnology company dedicated to outpacing cancer through early detection. Their intelligent screening platform utilizes multiomics technology and artificial intelligence, combined with a standard blood draw, to identify cancer in its earliest, most treatable stages. This approach aims to make a significant difference by enabling earlier intervention and improving patient outcomes.
Key facts
At-a-glance profile data
- Website
- freenome.com
- Headquarters
- South San Francisco, California, USA
- Founded
- 2014
- Employees
- 402
- Total funding
- $570M (Series D)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 3 Feb 2021 | Series D | $300M | Perceptive Advisors, RA Capital |
| 19 Aug 2020 | Series C | $270M | RA Capital, Fidelity Investments |
Tech stack
Detected on freenome.com, last scanned 18 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- Support
- HubSpot
- CMS / Builders
- WordPress
- Email provider
- Google Workspace
- Cookie consent
- OneTrust
Frequently asked
How much funding has Freenome raised?
Freenome has raised a total of $570M in funding. The most recent round on record is Series D.
How many employees does Freenome have?
Freenome has approximately 402 people on record.